Neuropathological stageing of Alzheimer-related changes

1991/09/01 by H. Braak, Heiko Braak, E. Braak +1 · 16,435 citations
Chemistry · Medicine · Neuroscience · #Alzheimer's disease #Alzheimer's disease research and treatments #Amyloid (mycology) #Anatomy #Autopsy #Biology #Central nervous system #Chemistry #Cortex (anatomy) #Dementia and Cognitive Impairment Research #Disease #Entorhinal cortex #Hippocampus #Medicine #Memory and Neural Mechanisms #Neurofibrillary tangle #Neuropil #Neuroscience #Pathology #Senile plaques

paper · doi:10.1007/bf00308809

published in Acta Neuropathologica 82(4), 239-259 (Springer Science+Business Media)

openalex publication_date 1991/09/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05

Cited by

• Synaptic degeneration in Alzheimer’s disease
• Distribution patterns of tau pathology in progressive supranuclear palsy
• Roles of tau protein in health and disease
• National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
• Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
• Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy
• The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
• Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons
• Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer’s disease
• Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia
• APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology
• The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
• Regulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis
• Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions
• Mothering a Female Saint: Susan Warner's Dialogic Role in 'The Wide, Wide World.'
• Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology
• Prediction of Dementia by Subjective Memory Impairment<subtitle>Effects of Severity and Temporal Association With Cognitive Impairment</subtitle><alt-title>Dementia and Subjective Memory Impairment</alt-title>
• Regional Distribution of Neurofibrillary Tangles and Senile Plaques in the Cerebral Cortex of Very Old Patients
• Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
• Conformational Changes Specific for Pseudophosphorylation at Serine 262 Selectively Impair Binding of Tau to Microtubules
• Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease
• Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer’s disease
• Age impairs mnemonic discrimination of objects more than scenes: A web-based, large-scale approach across the lifespan
• Amyloid assembly and disassembly
• DSCR1 upregulation enhances dural meningeal lymphatic drainage to attenuate amyloid pathology of Alzheimer's disease
• Improved Detection of Substantia Nigra Pathology in Alzheimer's Disease
• Axonal pathology in traumatic brain injury
• Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration
• Molecular pathology of neurodegenerative diseases: principles and practice
• The human entorhinal cortex: A cytoarchitectonic analysis
• Assessing individual variability of the entorhinal subfields in health and disease
• Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI
• Microglial Activation parallels System Degeneration in progressive Supranuclear palsy and Corticobasal Degeneration
• Mild cognitive impairment and on to dementia
• Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
• Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
• Neuropathology of Cognitively Normal Elderly
• Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62
• Visual Association Pathology in Preclinical Alzheimer Disease
• Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
• The intricate role of CCL5/CCR5 axis in Alzheimer disease
• Cerebral Small Vessel Disease-Induced Apolipoprotein E Leakage Is Associated With Alzheimer Disease and the Accumulation of Amyloid β-Protein in Perivascular Astrocytes
• Characteristics of Dyshoric Capillary Cerebral Amyloid Angiopathy
• Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy
• Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies
• Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
• 7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature
• Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
• The Revised National Alzheimer’s Coordinating Center’s Neuropathology Form—Available Data and New Analyses
• The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases
• Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease
• Integrated multimodal cell atlas of Alzheimer’s disease
• Chronic pain in Alzheimer disease and the role of neuroimmune interactions
• Vision function abnormalities in Alzheimer disease
• Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer’s disease
• Hippocampal GABAergic Inhibitory Interneurons
• The Microbiota-Gut-Brain Axis
• Impaired perceptual discrimination of complex objects in older adults at risk for dementia
• Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer's disease, and primary age‐related tauopathy hippocampi
• Amyloid-β and tau deposition in traumatic brain injury: a study of Vietnam War veterans
• Comparison of histological delineations of medial temporal lobe cortices by four independent neuroanatomy laboratories
• MCR-VQGAN: A Scalable and Cost-Effective Tau PET Synthesis Approach for Alzheimer's Disease Imaging
• Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
• Detecting Discontinuities in the Topology of Alzheimers gene Co-expression
• Longitudinal Evaluation of 18 F-MK-6240 Along the Alzheimer Disease Continuum
• Entorhinal cortex dysfunction in Alzheimer's disease
• The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis
• Phosphorylated tau aggregation in the brains of aged Artiodactyla animals
• Optimal stimulation sites are not the most affected: personalised models of resting-state fMRI in Alzheimer's disease
• Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus
• The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease
• Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease
• Krüppel-like Factor 8 Ameliorates Alzheimer's Disease by Activating β-Catenin
• Calcium signaling in individual APP/PS1 mouse dentate gyrus astrocytes increases ex vivo with Aβ pathology and age without affecting astrocyte network activity
• Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease
• Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
• Aging and Alzheimer's disease pathology
• Corticobasal degeneration with visual hallucination as an initial symptom: A case report
• La patria como tema y sus variaciones en tres poemarios representativos de Lucía Muñoz Maceo
• Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference
• Pattern separation and pattern completion in Alzheimer's disease: Evidence of rapid forgetting in amnestic mild cognitive impairment
• Reactive astrocytes in Alzheimer’s disease: A double-edged sword
• A cognitive–motor framework for spatial navigation in aging and early-stage Alzheimer's disease
• Elevated locus coeruleus metabolism provides resilience against cognitive decline in preclinical Alzheimer's disease
• Cortical gray–white matter contrast alterations precede amyloid‐β positivity and macrostructural changes in older adults without dementia
• Smartphone-based detection of subtle memory decline in prodromal Alzheimer’s disease
• Molecular Dynamics Study of the Binding of Cationic, Anionic, and Neutral Luminescent Conjugated Ligands to the Alzheimer Folds of A β (1–42) and Tau Fibrils
• The measurement of everyday cognition (ECog): Scale development and psychometric properties.
• Brain volume change and cognitive trajectories in aging.
• Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
• Genetic convergence in brain aging and neurodegeneration: from cellular mechanisms to therapeutic targets
• Reconstructing Subject-Specific Effect Maps
• A systematic comparison of ATN biomarkers for monitoring longitudinal cognitive changes in Alzheimer's disease
• 3D imaging of neuronal inclusions and protein aggregates in human neurodegeneration by multiscale x‐ray phase‐contrast tomography
• Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies
• Neural Metabolic Networks: Key Elements of Healthy Brain Function
• Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease
• S-Chain: Structured Visual Chain-of-Thought For Medicine
• Understanding Mechanistic Role of Structural and Functional Connectivity in Tau Propagation Through Multi-Layer Modeling
• Structural imaging of hippocampal subfields in healthy aging and Alzheimer’s disease
• Sex differences for regional pathology in people with a high likelihood of Lewy body dementia phenotype based on underlying pathology
• pTau pathology in the retina of TAU58 mice: association with ganglion cell degeneration and implications on seeding and propagation of pTau from human brain lysates
• Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity
• Endothelial Cells Are Heterogeneous in Different Brain Regions and Are Dramatically Altered in Alzheimer's Disease
• Staging of brain pathology related to sporadic Parkinson’s disease
• Reserve, resilience and maintenance of episodic memory and other cognitive functions in aging
• Disentangling Neurodegeneration with Brain Age Gap Prediction Models: A Graph Signal Processing Perspective
• Tau, atrophy, and domain‐specific cognitive impairment in typical Alzheimer's disease
• Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer’s disease
• Developing a novel reference region for [18F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies
• Late-onset unexplained seizures are associated with cognitive impairment and lower amygdala volumes
• Tau filaments are tethered within brain extracellular vesicles in Alzheimer’s disease
• Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer’s, vascular and Lewy body dementias
• Synaptic gene expression changes in frontotemporal dementia due to the MAPT 10 + 16 mutation
• Automated Imaging Differentiation for Dementia
• Selective reduction of ADAM10 in brain and cerebrospinal fluid of Alzheimer’s disease patients
• Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline
• Quantification of Protein Secondary Structures from Discrete Frequency Infrared Images Using Machine Learning
• Plasma p-tau217 and glucose metabolism correlate in neocortical association areas in Alzheimer's disease
• Tau Protein Squired by Molecular Chaperones During Alzheimer’s Disease
• Automated bimodal pause analysis for acoustic markers of cognitive decline and Alzheimer's disease in connected speech
• Modifiable risk factor profiles moderate the effect of β-amyloid pathology on cognition in aging
• Biological age acceleration in Alzheimer’s disease modulates relative cortical to medial temporal lobe neurodegeneration
• Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations
• Primary retinal tauopathy: A tauopathy with a distinct molecular pattern
• Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer’s Disease
• Depth- and curvature-based quantitative susceptibility mapping analyses of cortical iron in Alzheimer’s disease
• Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology
• Synaptic density and tau pathology in Alzheimer’s disease: a dual role in susceptibility and degeneration
• Maintaining and regaining episodic memory in Alzheimer disease: a circuit-based perspective
• Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer’s disease progression
• Multivariate MR Biomarkers Better Predict Cognitive Dysfunction in Mouse Models of Alzheimers Disease
• Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
• Self-Supervised Cross-Encoder for Neurodegenerative Disease Diagnosis
• Network Models of Neurodegeneration: Bridging Neuronal Dynamics and Disease Progression
• TauGenNet: Plasma-Driven Tau PET Image Synthesis via Text-Guided 3D Diffusion Models
• Latent space projections and atlases: A cautionary tale in deep neuroimaging using autoencoders
• The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias
• Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease
• Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex
• Network-guided analysis of hippocampal proteome identifies novel proteins that colocalize with Aβ in a mice model of early-stage Alzheimer’s disease
• EEG-MSAF: An Interpretable Microstate Framework uncovers Default-Mode Decoherence in Early Neurodegeneration
• α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects
• Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
• The effect of Alzheimer’s biomarker positivity on neuropsychological networks
• Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases
• Estrogens, inflammation and cognition
• A complex network perspective on brain disease
• CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis
• Dual-action peptide shuttles rescue Cu-amyloid-β-induced neurotoxicity and relocate Cu intracellularly
• Morphological and Hyperphosphorylation Transitions of Nanoscale Tau Aggregates in Alzheimer's Disease
• Judged by your neighbors: A novel framework for personalized assessment of brain structural aging effects in diverse populations
• Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease
• Tensor Generalized Estimating Equations for Longitudinal Imaging Analysis
• Towards a quantitative assessment of neurodegeneration in Alzheimer's disease
• Olfaction and declarative memory in aging: a meta-analysis
• REVIEW: tau protein pathology in Alzheimer’s disease and related disorders
• Directionality bias underpins divergent spatiotemporal progression of Alzheimer‐related tauopathy in mouse models
• Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells
• Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer’s Disease: Recent Advances and Perspectives
• MPP-GNN: Subject-Adaptive Community Detection for fMRI-Based Alzheimer's Disease Classification
• The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease
• Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update
• Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of aging cohort
• Retrospective analysis of Braak stage– and APOE4 allele–dependent associations between MR spectroscopy and markers of tau and neurodegeneration in cognitively unimpaired elderly
• A microglia clonal inflammatory disorder in Alzheimer’s disease
• Episodic memory on the path to Alzheimer's disease
• Harmonized Protocol for Subfield Segmentation in the Hippocampal Body on High‐Resolution In Vivo MRI From the Hippocampal Subfields Group ( HSG )
• The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer’s Disease
• Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline
• Beyond episodic memory: Semantic processing as independent predictor of hippocampal/perirhinal volume in aging and mild cognitive impairment due to Alzheimer’s disease.
• The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals
• Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis
• Distinct Conformers of Assembled Tau in Alzheimer's and Pick's Diseases
• Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
• REAL AD—Validation of a realistic screening approach for early Alzheimer's disease
• DeepHIPS: A novel Deep Learning based Hippocampus Subfield Segmentation method
• Adult Hippocampal Neurogenesis in Aging and Alzheimer's Disease
• Multimodal deep learning for Alzheimer’s disease dementia assessment
• Functional connectivity tracks clinical deterioration in Alzheimer's disease
• miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease
• The utility of Stroop task switching as a marker for early-stage Alzheimer's disease.
• Network models to enhance the translational impact of cross-species studies
• Brain aging mechanisms with mechanical manifestations
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
• Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease
• Distribution of β‐amyloid protein in the brain following severe head injury
• Evolution of the neuropathology of Alzheimer's disease
• Pattern formation in a Reaction-Diffusion Model for Amyloid-β and Tau Interactions in Alzheimer's Disease
• Direct cortical thickness estimation using deep learning‐based anatomy segmentation and cortex parcellation
• Feynman Kac Reweighted Schrödinger Bridge Matching for Surface-Based Tau PET Harmonization
• The apolipoprotein E gene, attention, and brain function.
• Gender Modulates the APOE 4 Effect in Healthy Older Adults: Convergent Evidence from Functional Brain Connectivity and Spinal Fluid Tau Levels
• Relevance of a Novel Circuit-Level Model of Episodic Memories to Alzheimer’s Disease
• Cross-scale spatially-aware generative modeling of transcriptomic programs underlying neurodegenerative brain organization
• Galactic Cosmic Radiation Leads to Cognitive Impairment and Increased Aβ Plaque Accumulation in a Mouse Model of Alzheimer’s Disease
• d-serine levels in Alzheimer’s disease: implications for novel biomarker development
• SC-TauPath: A Structural Connectivity Attribution Framework for Mapping Tau Propagation Pathways in Alzheimer's Disease
• EPS Mid-Career Award 2006: Understanding anterograde amnesia: Disconnections and hidden lesions
• Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
• The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
• An explainable framework for the relationship between dementia and glucose metabolism patterns
• The spectrum of disease in chronic traumatic encephalopathy
• Neuronal cytoskeletal changes are an early consequence of repetitive head injury
• The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy
• Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players
• Long-Term Consequences: Effects on Normal Development Profile After Concussion
• Behavior Score Prediction in Resting-State Functional MRI by Deep State Space Modeling
• Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases
• MethConvTransformer: A Deep Learning Framework for Cross-Tissue Alzheimer's Disease Detection
• Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
• Outcome-guided Sparse K-means for Disease Subtype Discovery via Integrating Phenotypic Data with High-dimensional Transcriptomic Data
• Plasma IL-6 Levels as a Biomarker for Behavioral Changes in Alzheimer’s Disease
• A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging
• Eva Braak [wikipedia]
• Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. [europepmc]
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. [europepmc]
• Neurodegenerative diseases target large-scale human brain networks. [europepmc]
• Transmission and spreading of tauopathy in transgenic mouse brain. [europepmc]
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. [europepmc]
• The clinical use of structural MRI in Alzheimer disease. [europepmc]
• Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. [europepmc]
• Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. [europepmc]
• National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. [europepmc]
• National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. [europepmc]
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. [europepmc]
• Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. [europepmc]
• Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. [europepmc]
• Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. [europepmc]
• Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. [europepmc]
• Primary age-related tauopathy (PART): a common pathology associated with human aging. [europepmc]
• Depletion of microglia and inhibition of exosome synthesis halt tau propagation. [europepmc]
• Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. [europepmc]
• Single-cell transcriptomic analysis of Alzheimer's disease. [europepmc]
• The neuropathological diagnosis of Alzheimer's disease. [europepmc]
• Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. [europepmc]
• Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. [europepmc]
• Alzheimer disease. [europepmc]
• Inflammation in obesity, diabetes, and related disorders. [europepmc]
• Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. [europepmc]